Metformin Outperforms Common Class of Diabetes Drugs in Study

<p>SUNDAY, Jun 24 (<span>HealthDay News</span>) — Three widely used <span>diabetes</span>
drugs are compared with a larger risk of genocide when compared to a
popular drug from a opposite class, <span>metformin</span>, according to a new
study.</p>
<p>Researchers analyzed information from scarcely 24,000 patients with form 2
diabetes, normal age 62, who were treated with one of 3 drugs called<span>sulfonylureas</span> (glipizide, glyburide, and glimepiride) or with another type
of drug called metformin.</p>
<p>Sulfonylureas assistance diminution <span>blood sugarine levels</span> by sensitive the
pancreas to furnish insulin. Metformin also helps revoke blood sugar
levels.</p>
<p>Overall, all 3 sulfonylureas were compared with a some-more than 50
percent larger risk of genocide compared to metformin, according to the
study, that was saved by drug association Astra Zeneca.</p>
<...